Wilson Sonsini Goodrich & Rosati advised Elucidata on the transaction. TechBio company Elucidata announced that it has raised $16 million in a Series A fundraising, which...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Investor Time BioVentures on the deal while WilmerHale represented Phantom Neuro. Phantom Neuro, the first-of-its-kind neurotech startup that delivers a low power, high...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Think Bioscience on the deal. Think Bioscience, a synthetic biology company focused on developing small-molecule therapeutics that target difficult-to-drug proteins, announced it has...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Faeth Therapeutics on the deal. Faeth Therapeutics, a cancer metabolism company, announced the completion of a Series A financing of $47 million led...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised NAPIGEN on the deal. NAPIGEN, a company developing proprietary technology to edit mitochondrial and chloroplast genomes, announced the completion of $7.85 million seed...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised VitroLabs on the deal. VitroLabs Inc, a Bay-Area-based biotech company leading the development of a new scientific process to grow the world’s first...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised ArrePath on the deal. ArrePath, an anti-infective drug discovery company addressing drug resistant infections, announced it has raised $20 million in seed financing...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Iterative Scopes on the deal. Iterative Scopes, a pioneer in the development of precision-based gastrointestinal (GI) disease technologies and software,...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Aramis Biosciences on the deal. Aramis Biosciences, a clinical-stage immuno-ophthalmology biopharmaceutical company, announced its launch and the completion of a...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised FREYR on the deal. FREYR Battery, a developer of clean, next-generation battery cell production capacity, announced the formation of a...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Vida Ventures on the deal while Goodwin Procter represented Vigil Neuroscience. Vigil Neuroscience, a biotechnology company harnessing the power of...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Iterative Scopes on the deal. Iterative Scopes, a pioneering company aiming to bring cutting-edge precision medicine to gastroenterology, closed a...
You must be a Standard 1 Year member to access this content.
